EN
抗体药类似物
Research Grade Romilkimab
All
TD-HW632046_1.jpg
TD-HW632046_2.jpg
  • CatalogTD-HW632046
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBispecific, SAR156597, huTBTI3_2_1, CAS: 1399584-78-1
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Romilkimab


Catalog No. TD-HW632046
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype [VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target IL13, NC30, Interleukin-13, IL-13, Binetrakin, B-cell stimulatory factor 1, Pitrakinra, Lymphocyte stimulatory factor 1, IL-4, BSF-1, IL4, Interleukin-4
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P35225 & P05112
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names Bispecific, SAR156597, huTBTI3_2_1, CAS: 1399584-78-1
Background Romilkimab (SAR156597) is a chimeric humanized IG antibody that specifically targets IL-4 and IL13.
Note For research use only. Not suitable for clinical or therapeutic use.

 

TD-HW632046_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Romilkimab
TD-HW632046_2.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Romilkimab.